Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03360110 · ClinicalTrials.gov registry record · NA
Comparison of New Contact Lens With Current Marketed Lens
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT03360110: Completed NA study, sponsored by CooperVision.
NCT03360110 is a NA study that has completed, run by CooperVision. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03360110, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of this study is to validate the clinical performance of a new contact lens design.
Primary Outcome
Measurement of extent of corneal staining using Fluorescein, blue light, yellow filter, full beam, medium magnification on a scale 0-4 (0=no staining, 1 = 1-15% of area, 2= 16-30% of area, 3=31-45% of area, 4=\>45% of area).
Interventions
- DEVICE Phoebe test lens
- DEVICE stenfilcon A lens (control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2017-12-15 |
| Phase | NA |
What the finished NCT03360110 record still lists
NCT03360110 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Phoebe test lens is the first listed.
NCT03360110 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03360110 about?
NCT03360110 is a clinical study titled "Comparison of New Contact Lens With Current Marketed Lens". The purpose of this study is to validate the clinical performance of a new contact lens design.
What is the current status of trial NCT03360110?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2017-11-06. Estimated completion is 2017-12-15.
What interventions are being tested in trial NCT03360110?
The interventions under investigation include: Phoebe test lens (DEVICE), stenfilcon A lens (control) (DEVICE).
Who is sponsoring clinical trial NCT03360110?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03360110's enrollment target sits among peer trials
53 1271st of 2000 higher than 729 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI